Skip to content

Koppers Holdings KOP Depreciation in impairment and restructuring

Depreciation in impairment and restructuring at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%
Doximity logo
DoximityDOCS
$0-100%
VC
VisteonVC
$18M
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$0+100%
Under Armour logo
Under ArmourUAA
$8.01M-49.1%
ALH
Alliance Laundry Holdings Inc.ALH
$0-100%

Other financials

Income statement

See full
Revenue$455.3M-0.3%
Gross profit$86.6M-18.1%
Operating income$22.0M-18.5%
Net income$7.1M+151%
EPS (diluted)$0.35+151%

Balance sheet

See full
Cash & equivalents$42.8M+28.5%
Total debt$1.0B-4.3%
Total equity$549.5M+10.3%
Total assets$1.9B-0.6%

Cash flow

See full
Operating cash flow$46.3M+304%
CapEx$11.4M-20.3%
Free cash flow$34.9M+194%

Valuation

See full
Market cap$859.66M+37.3%
Enterprise value$1.84B+10.7%
P/E11.2×
P/S0.5×+0.2×

Profitability

See full
Gross margin22.8%+1.7pp
Operating margin8.7%+1.8pp
Net margin4.1%
FCF margin7.4%

Returns & leverage

See full
Return on equity14.7%
Debt / equity1.9×-0.3×
Current ratio2.7×+0.1×

Where this comes from

Reported directly by Koppers Holdings in its filing.

Tagged under the XBRL concept kop:DepreciationInImpairmentAndRestructuring.

The official record: Koppers Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Koppers Holdings's depreciation in impairment and restructuring.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Koppers Holdings's depreciation in impairment and restructuring?
Koppers Holdings (KOP) reported depreciation in impairment and restructuring of $0 in Q1 2026.
How has Koppers Holdings's depreciation in impairment and restructuring changed year-over-year?
Koppers Holdings's depreciation in impairment and restructuring decreased by 100.0% year-over-year, from $12.2M to $0.
What does depreciation in impairment and restructuring mean?
This metric captures the accelerated depreciation or write-downs associated with asset impairments and organizational restructuring activities. It highlights non-recurring adjustments to asset values resulting from strategic shifts or operational inefficiencies.